Dana-Farber/Brigham and Women’s Adult Hematologic Oncology Treatment Center is one of the world’s largest and most respected treatment centers for patients with disorders of the blood or bone marrow as well as all types of cancers of the blood, including leukemia, lymphoma, multiple myeloma and Waldenström’s macroglobulinemia, as well as related disorders of the blood, such as aplastic anemia and myelodysplasia.

Because hematological disorders take many different forms, your care team includes experts with specialized knowledge in treating your condition. The Center also conducts a wide range of clinical research to evaluate potential new therapies.

Our physicians, radiologists, nurse practitioners, and other specialists work closely together to develop a treatment approach tailored to the unique characteristics of your disease and to accommodating your needs.

DSC_3771_smOur Contributions

Hematopathologists, molecular pathologists, and hematologic oncologists at Dana-Farber/Brigham and Women’s Cancer Center have developed and implemented a new genetic test that is improving and accelerating the diagnosis and management of patients with leukemias, myelodysplastic syndromes, and myeloproliferative disorders.

Learn More

The Latest Thinking

FDA Approves 1st Targeted Drug for Certain Leukemia Patients Read More

Personalized tumor vaccines keep cancer in check Read More

Studies highlight potential for genomic testing in pediatric cancers Read More

SOG_5666_14_smWhat to Expect

The Center is dedicated to providing patients with expert medical care during the entire course of treatment, from diagnosis, to the delivery of therapy, to follow-up care once treatment is completed.

Learn More